Agilent Technologies
A · Life Sciences Tools & Services
$173.07
0.5%Avantor
AVTR · Life Sciences Tools & Services
$17.29
0.8%The short version
- Agilent Technologies is the larger business, with $6.9B of revenue in fiscal 2025 against $6.6B for Avantor.
- Agilent Technologies grew revenue faster (6.7%, against −3.4%).
- Agilent Technologies kept more of each dollar of sales as operating profit (21.3% operating margin, against −3.8% operating margin).
- Agilent Technologies turned more of its sales into free cash flow (16.6% FCF margin, against 7.6% FCF margin).
- Agilent Technologies earned a higher return on the capital invested in it (16.5%, against −2.1%).
| Latest fiscal year | A · FY25 | AVTR · FY25 |
|---|---|---|
| Size | ||
| Market cap | $49.0B | $11.7B |
| Revenue | $6.9B | $6.6B |
| Free cash flow | $1.2B | $495M |
| Net income | $1.3B | −$530M |
| Growth | ||
| Revenue growth | 6.7% | −3.4% |
| 5-year growth | 5.4% | 0.5% |
| Share count change | −2.1% | −0.2% |
| Profitability | ||
| Gross margin | 52.4% | 32.7% |
| Operating margin | 21.3% | −3.8% |
| Net margin | 18.8% | −8.1% |
| FCF margin | 16.6% | 7.6% |
| Return on capital | 16.5% | −2.1% |
| Return on equity | 20.6% | −9.2% |
| Balance sheet | ||
| Net debt | $1.6B | $3.6B |
| Net debt / EBITDA | 0.9x | 22.0x |
| Dividends and buybacks | $707M | $75.1M |
| Valuation & quality | ||
| P/E | 34.1x | — |
| Piotroski F-score | 5 | 5 |
FY16
A $4.2B
AVTR —
FY17
A $4.5B
AVTR $1.2B
FY18
A $4.9B
AVTR $5.9B
FY19
A $5.2B
AVTR $6.0B
FY20
A $5.3B
AVTR $6.4B
FY21
A $6.3B
AVTR $7.4B
FY22
A $6.8B
AVTR $7.5B
FY23
A $6.8B
AVTR $7.0B
FY24
A $6.5B
AVTR $6.8B
FY25
A $6.9B
AVTR $6.6B
A
AVTR
FY16
A 14.6%
AVTR —
FY17
A 18.1%
AVTR −16.9%
FY18
A 18.4%
AVTR 7.1%
FY19
A 18.2%
AVTR 9.1%
FY20
A 15.9%
AVTR 11.1%
FY21
A 21.3%
AVTR 13.2%
FY22
A 23.6%
AVTR 15.0%
FY23
A 19.8%
AVTR 10.0%
FY24
A 22.9%
AVTR 16.0%
FY25
A 21.3%
AVTR −3.8%
A
AVTR
FY16
A $654M
AVTR —
FY17
A $713M
AVTR −$193M
FY18
A $910M
AVTR $163M
FY19
A $866M
AVTR $302M
FY20
A $802M
AVTR $868M
FY21
A $1.3B
AVTR $843M
FY22
A $1.0B
AVTR $710M
FY23
A $1.5B
AVTR $724M
FY24
A $1.4B
AVTR $692M
FY25
A $1.2B
AVTR $495M
A
AVTR
FY16
A 14.5%
AVTR —
FY17
A 17.7%
AVTR —
FY18
A 10.9%
AVTR —
FY19
A 19.0%
AVTR 9.2%
FY20
A 12.5%
AVTR 9.6%
FY21
A 19.3%
AVTR 8.1%
FY22
A 19.8%
AVTR 8.4%
FY23
A 17.9%
AVTR 5.1%
FY24
A 16.9%
AVTR 8.9%
FY25
A 16.5%
AVTR −2.1%
A
AVTR
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.